A revolutionary immunotherapy has stunned doctors by making an aggressive, previously incurable blood cancer vanish in some ...

Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Head and neck cancer affects the Black community differently. These questions will help you make informed decisions about ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast tissue cell growth in a Northwestern University study.

Adding CAN-2409 to standard radiation therapy significantly improved disease-free survival and pathological complete response ...

Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

Multiple myeloma is considered incurable, but a third of patients in a clinical trial have lived without detectable cancer for years, after facing certain death ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...